Adiponectin was reported to reduce NAFLD inflammation through the AMPK-JNK/ErK1/2-NFκB/ROS signaling pathway, also exhibiting insulin sensitization and liver protection (196). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.